CE Marked Panel Detects 21 Respiratory Pathogens
Luminex Corporation has received CE-IVD marking for its NxTAG® Respiratory Pathogen Panel. The Panel detects 21 clinically-relevant viral and bacterial respiratory pathogens, including the atypical bacteria Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila. The NxTAG Respiratory Pathogen Panel is the only respiratory assay that easily enables laboratories to simultaneously detect 21 respiratory pathogens in a single closed tube system that scales to accommodate changes in throughput needed to respond to seasonal changes in demand, such as during flu season.
The NxTAG Respiratory Pathogen Panel requires only minutes of hands-on time with no upstream reagent preparation. The simplified workflow allows extracted samples to be added directly to pre-plated, lyophilized reagents. The tubes are then sealed and ready for closed tube amplification and subsequent detection using the Luminex MAGPIX® instrument. The innovative tube strip design offers laboratories the flexibility to manage variable sample demand by processing a single sample or up to as many as 96 samples per run, without wasting consumables or reagents, or the need to have full batches. Total turnaround time is just over three hours for 96 samples (excluding extraction).
In addition, the accompanying SYNCT™ Software provides a comprehensive approach to data analysis and reporting, and enables the NxTAG Respiratory Pathogen Panel to integrate easily into any laboratory. Any of a number of targets can be selected by laboratories to customize their testing panel.
To learn more, please visit Luminex at: www.luminexcorp.com/NxTAG-RPP
Tags: Legionella, Mycoplasma, Respiratory Virus, Respiratory Syncytial Virus, Legionella pneumophila, Respiratory panel
Date Published: October 20, 2015
Source article link: Luminex Corporation » company contact details
rqmicro Introduces New Kits for Legionella pneumophila SG1-15 and Other Pathogens
QIAGEN Launches QIAstat-Dx® in Europe
Automating the Diagnosis of Urogenital Mycoplasma Infections
Rapid Mycoplasma Testing Method Now Accepted by Regulators for QA/QC and Lot Release